NCT04521088 is a clinical trial in COVID-19, sponsored by Wissenschaftliches Institut Bethanien e.V.

Who is sponsoring NCT04521088?

NCT04521088 is sponsored by Wissenschaftliches Institut Bethanien e.V.

Is NCT04521088 still recruiting?

NCT04521088 is currently completed. Last updated 27 April 2022.

Last reviewed 2022-04-27 · How we verify

NCT04521088

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic

Completed Last updated 27 April 2022

What this trial tests

trial in COVID-19 in 1,316 participants. Completed in 31 July 2021.

Timeline

2 July 2020

Primary endpoint
30 May 2021

31 July 2021

Quick facts

Lead sponsor	Wissenschaftliches Institut Bethanien e.V
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,316
Start date	2 July 2020
Primary completion	30 May 2021
Estimated completion	31 July 2021
Sites	1 location across Germany

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

Wissenschaftliches Institut Bethanien e.V

Who can join

Eligibility, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is insufficient knowledge about transmission routes and the effectiveness of general protective measures to prevent infection, such as the closure of schools or the wearing of mouthguards. This will be illustrated using the example of the COVID-19 outpatient clinic in Solingen and the positive COVID-19 tests registered there. Another aspect we would like to address in this study is the number of COVID-19 tests performed against the background of political events or dramatic accumulations of COVID-19 cases in other parts of Germany or Europe. Do speeches by political leaders about the COVID-19 situation or a very strong regional spread of infection elsewhere have an impact on the frequency with which people react sensitively to suspicious symptoms and undergo testing for infection?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Initial Proportion and Dynamic of B.1.1.7 SARS-CoV-2 in a Large City in the West of Germany.
Herkenrath SD, Boschung K, Nacov JA, Heibges A, et al · · 2022 · PMID 35433711 · DOI 10.1159/000519968

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Wissenschaftliches Institut Bethanien e.V trials

Trials by the same sponsor.

NCT06861686 — A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores · recruiting
NCT06179342 — Multiple Breath Washout as a Method for Diagnosing Lung Diseases · completed
NCT04527497 — Clinical Course and Treatment of COVID-19 Inpatients in Hospital · completed
NCT04695678 — Epidemiological Multicohort Study of Latent COVID-19 Infections · completed
NCT04093427 — Influence of an Inverse Pressure Ramp in Long-term Non-invasive Ventilation on Dyspnea in the Morning After Therapy · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04521088 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wissenschaftliches Institut Bethanien e.V
Last refreshed: 27 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04521088.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing